Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

Summary

Bio-Techne launched an expanded portfolio of AI-engineered designer proteins including heat-stable and hyperactive variants of fibroblast growth factor and interleukin cytokines designed to advance cell therapy and cell culture workflows.